Publication:


abstract


Related Articles
Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006.
Nephrology (Carlton). 2011
Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006.
Kendrick-Jones JC, Voss DM, De Zoysa JR. Nephrology (Carlton). 2011 Feb; 16(2):243-8.
Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.
Eur J Dermatol. 2009
Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.
Chen W, Huang SL, Huang CS, Tsai MC, Lai HM, Lui CC, Eng HL, Chang HW, Lee CH, Chuang FR. Eur J Dermatol. 2009 Jan-Feb; 19(1):44-9. Epub 2008 Dec 5.
Review Nephrogenic systemic fibrosis: a concise review for cardiologists.
Tex Heart Inst J. 2010
Review Nephrogenic systemic fibrosis: a concise review for cardiologists.
Cheong BY, Muthupillai R. Tex Heart Inst J. 2010; 37(5):508-15.
Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
Hemodial Int. 2010
Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
Panesar M, Boateng F, Patel SS, Masood SF, Mahajan P, Patel N, Murray B. Hemodial Int. 2010 Jul; 14(3):289-94.
Review Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Nephrol Nurs J. 2007
Review Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Hamilton-Persaud K, Ezell LD, Macklin JG. Nephrol Nurs J. 2007 May-Jun; 34(3):283-7; quiz 288.